Impulsivity and D2 Receptor Function: Behavioral and PET Correlates
冲动性和 D2 受体功能:行为和 PET 相关性
基本信息
- 批准号:8058640
- 负责人:
- 金额:$ 3.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAgonistBehaviorBehavioralBindingBlinkingBrainBrain regionCerebrumCognitionCognitiveCorpus striatum structureDecision MakingDeoxyglucoseDevelopmentDiseaseDopamineDopamine AgonistsDopamine D2 ReceptorDoseDrug abuseEconomicsExhibitsFamilyImaging TechniquesImpulsivityIndividualIndividual DifferencesIntakeInvestigationLaboratoriesLeadLeftLinkMeasurementMeasuresMediatingMolecularMolecular ConformationMonkeysPatient Self-ReportPharmaceutical PreparationsPhenotypePopulationPositron-Emission TomographyPrevention strategyProcessRiskRoleShort-Term MemorySocietiesSubstance AddictionSubstance abuse problemSynapsesSystemTechniquesTemperamentVariantbasebehavior measurementbiobehaviorbiological systemscaudate nucleuscognitive controldopamine systemflexibilityfunctional outcomesglucose metabolismin vivoinsightneuroimagingneuromechanismnonhuman primatepre-clinical researchradioligandreceptorreceptor expressionreceptor functionrelating to nervous systemresearch studyresponsesocialtraittreatment strategy
项目摘要
DESCRIPTION (provided by applicant): The economic and social burdens on society that are a direct result of substance dependence are enormous. As such, determining the neural mechanisms of phenotypes that confer risk for the development of this disorder is crucial for advancing scientifically-based prevention and treatment strategies. Associations between variation in cognitive processes and substance dependence liability have been demonstrated, and the corticostriatal dopamine system has been implicated in these relationships. Further, recent evidence has demonstrated an important role of the dopamine D2 receptor in controlling aspects of impulsivity, cognitive control and drug abuse. Therefore, the D2 receptor may represent a mechanistic link between cognitive control processes and risk for the development of substance dependence. Because the D2 receptor can exist in two conformational states - a state in which dopamine displays high affinity for the receptor and has greater functional activity, and a state in which dopamine displays less affinity for the receptor and is less functionally active - determining whether variation in receptor availability detected with standard neuroimaging techniques (i.e. PET) reflect variation in receptor state (high versus low) is critical to understanding the relationship between cognitive processes and risk for substance dependence. Because we have found an association between a naturally occurring variation of trait impulsivity and D2 radioligand binding in vivo, this proposal will attempt to examine this question using behavioral pharmacological techniques to probe D2-like receptor states (Aim 1) and using this information to examine a possible neural mechanism by which variation in receptor state may influence global brain function (Aim 2). These results will provide evidence for a mechanism by which variation within a biological system can influence higher- order processes that have direct relevance to substance dependence. The advancements in the characterization of the link between the D2 receptor system and impulsivity offered in this proposal will provide an important step in understanding how manipulations of the dopamine system may be utilized to enhance cognitive control and therefore mitigate risk for the development of substance dependence.
描述(由申请人提供):药物依赖直接导致的社会经济和社会负担是巨大的。因此,确定赋予这种疾病发展风险的表型的神经机制对于推进基于科学的预防和治疗策略至关重要。认知过程的变化和物质依赖倾向之间的关联已被证明,皮质纹状体多巴胺系统已被牵连在这些关系。此外,最近的证据已经证明了多巴胺D2受体在控制冲动、认知控制和药物滥用方面的重要作用。因此,D2受体可能代表了认知控制过程和物质依赖发展风险之间的机制联系。因为D2受体可以以两种构象状态存在-多巴胺对受体表现出高亲和力并具有更大的功能活性的状态,以及多巴胺对受体表现出较低亲和力和较低功能活性的状态--确定是否用标准神经成像技术检测到受体可用性的变化反映受体状态变化(高与低)的PET(即PET)对于理解认知过程与物质依赖风险之间的关系至关重要。因为我们已经发现了一个自然发生的变化的特质冲动和D2放射性配体结合在体内之间的关联,这个建议将试图研究这个问题,使用行为药理学技术探测D2样受体状态(目的1),并使用这些信息来研究一个可能的神经机制,受体状态的变化可能会影响全球的脑功能(目的2)。这些结果将为生物系统内的变异可以影响与物质依赖直接相关的高阶过程的机制提供证据。本提案中提供的D2受体系统和冲动性之间联系的表征进展将为理解如何利用多巴胺系统的操纵来增强认知控制并因此减轻物质依赖发展的风险提供重要的一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephanie Mary Groman其他文献
Stephanie Mary Groman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephanie Mary Groman', 18)}}的其他基金
Circuit-level neurodevelopmental trajectories of decision-making computations across adolescence
青春期决策计算的电路级神经发育轨迹
- 批准号:
10582133 - 财政年份:2022
- 资助金额:
$ 3.32万 - 项目类别:
Circuit-level neurodevelopmental trajectories of decision-making computations across adolescence
青春期决策计算的电路级神经发育轨迹
- 批准号:
10705252 - 财政年份:2022
- 资助金额:
$ 3.32万 - 项目类别:
Molecular Mechanisms of Susceptibility to Drug Use
吸毒易感性的分子机制
- 批准号:
10316306 - 财政年份:2021
- 资助金额:
$ 3.32万 - 项目类别:
Molecular Mechanisms of Susceptibility to Drug Use
吸毒易感性的分子机制
- 批准号:
10215467 - 财政年份:2021
- 资助金额:
$ 3.32万 - 项目类别:
Molecular Mechanisms of Susceptibility to Drug Use
吸毒易感性的分子机制
- 批准号:
10430189 - 财政年份:2021
- 资助金额:
$ 3.32万 - 项目类别:
Molecular Mechanisms of Susceptibility to Drug Use.
药物使用敏感性的分子机制。
- 批准号:
10936772 - 财政年份:2021
- 资助金额:
$ 3.32万 - 项目类别:
Molecular Mechanisms of Susceptibility to Drug Use
吸毒易感性的分子机制
- 批准号:
10653168 - 财政年份:2021
- 资助金额:
$ 3.32万 - 项目类别:
Molecular mechanisms of susceptibility to drug use
吸毒易感性的分子机制
- 批准号:
10029887 - 财政年份:2020
- 资助金额:
$ 3.32万 - 项目类别:
Identification of a non-invasive neuroimaging biomarker of prenatal synaptic development
产前突触发育的非侵入性神经影像生物标志物的鉴定
- 批准号:
9808337 - 财政年份:2019
- 资助金额:
$ 3.32万 - 项目类别:
Impulsivity and D2 Receptor Function: Behavioral and PET Correlates
冲动性和 D2 受体功能:行为和 PET 相关性
- 批准号:
8246495 - 财政年份:2010
- 资助金额:
$ 3.32万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 3.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 3.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 3.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)